By Steve Holland and Andrea Shalal WASHINGTON (Reuters) – If President Joe Biden is going to survive pressure to abandon his re-election campaign after a poor showing in his debate with Donald Trump, he needs to ace a gauntlet of events in coming days. As calls grow from some of his own Democrats to step…
(This story contains offensive language in paragraph 3) By Jeff Mason WASHINGTON (Reuters) – Republican Donald Trump falsely claimed to have driven Democratic President Joe Biden out of the White House race and disparaged Vice President Kamala Harris in a video published by the Daily Beast, which drew a sharp rebuke from the Biden campaign….
By Daniel Wiessner (Reuters) -Microsoft Corp has agreed to pay $14 million to settle a California agency’s claims that it illegally penalized workers who took medical or family-care leave, the agency said on Wednesday. The California Civil Rights Department in filings in state court accused the tech giant of retaliating against its California-based employees who…
By Chibuike Oguh NEW YORK (Reuters) -World equities rose while the U.S. dollar fell on Wednesday following soft labor market data that buoyed investor expectations of Federal Reserve interest rate cuts later this year. U.S. Labor Department data on Wednesday showed that initial claims for unemployment rose 238,000 the week that ended June 29, slightly…
By David Shepardson (Reuters) -General Motors will pay a $145.8 million penalty after a U.S. government investigation found excess emissions from approximately 5.9 million GM vehicles, government agencies said on Wednesday. The Environmental Protection Agency said GM has agreed to give up approximately 50 million metric tons in carbon allowances after the multi-year investigation found…
By Nandita Bose WASHINGTON (Reuters) – Vice President Kamala Harris is the top alternative to replace U.S. President Joe Biden if he decides not to continue his reelection campaign, according to seven senior sources at the Biden campaign, the White House and the Democratic National Committee with knowledge of current discussions on the topic. Biden’s…
The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly’s donanemab for patients with early Alzheimer’s, making it the second approved drug for slowing the progress of the brain-wasting disease. The approval for the drug branded Kisunla is in line with the recommendations of the agency’s outside experts who unanimously…
By Milana Vinn (Reuters) – Private equity firm Vista Equity is in talks to cede control of its company Pluralsight to lenders, according to three people familiar with the matter and fund documents reviewed by Reuters. The financial information in the documents sheds light on how Pluralsight is set to become the first major debt…
By Jonathan Stempel NEW YORK (Reuters) – Progressive agreed to pay $48 million to settle a class action lawsuit accusing the insurer of systematically undervaluing the claims of New York drivers whose vehicles were wrecked. A preliminary settlement of the proposed class action was filed on Monday night in federal court in Manhattan, and requires…
(Reuters) – Walmart has held talks with potential buyers to sell its already shuttered medical clinics, Fortune reported on Tuesday, citing multiple sources familiar with the matter. In April, Walmart decided to close all 51 of its health clinics and shut its virtual healthcare operations, saying it could not see them as a sustainable business…
